首页> 外文期刊>Veterinary Pathology >A Morphological Study of 608 Cases of Canine Malignant Lymphoma in France With a Focus on Comparative Similarities Between Canine and Human Lymphoma Morphology.
【24h】

A Morphological Study of 608 Cases of Canine Malignant Lymphoma in France With a Focus on Comparative Similarities Between Canine and Human Lymphoma Morphology.

机译:法国608例犬恶性淋巴瘤的形态学研究,重点是犬与人淋巴瘤形态的比较相似性。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

This study reports cytomorphological, histomorphological, and immunological characterization of 608 biopsy cases of canine malignant lymphoma, with epidemiological and clinical data, collected from 7 French veterinary pathology laboratories. It compares morphological characteristics of malignant lymphoma in canines, per the updated Kiel classification system, with those reported in humans, per the World Health Organization (WHO) classification system. Of tumors described, 24.5% and 75.5% were classified as low- and high-grade malignant lymphomas, respectively. Presenting clinical signs included generalized or localized lymphadenopathy (82.4%) and extranodal diseases (17.6%) involving the skin (12.34%) and other sites (5.26%). Immunohistochemistry confirmed 63.8% B-cell (CD3–, CD79a+), 35.4% T-cell (CD3+, CD79a–), and 0.8% null-cell (CD3–, CD79a–) lymphomas. Most B-cell cases (38.49%) were of high-grade centroblastic polymorphic subtype; most T-cell cases (8.55%), high-grade pleomorphic mixed and large T-cell lymphoma subtypes. Some B-cell tumors showed morphologic characteristics consistent with follicular lymphomas and marginal zone lymphomas per the Revised European American Classification of Lymphoid Neoplasms and WHO canine classification systems and the WHO human classification system. Unusual high-grade B-cell subtypes included an atypical high-grade small B-cell lymphoma (0.66%), Burkitt-type B-cell lymphoma (1.64%), plasmacytoid lymphoma (0.99%), and mediastinal anaplastic large B-cell lymphoma (0.16%). Unusual T-cell subtypes included a previously undescribed high-grade canine immunoblastic T-cell type (1.15%), a rare low-grade prolymphocytic T-cell lymphoma (0.16%), and a recently described high-grade canine T-cell entity—aggressive granulocytic large-cell lymphoma (0.16%). Marginal zone lymphomas were common (10.86%); follicular lymphomas were rare (0.49%). Canine primary cutaneous malignant lymphoma subtypes were present (11.84%). There was no significant difference between B- and T-cell malignant lymphoma in regard to canine age and sex. A significant overrepresentation of Boxers (24.19%) was found for T-cell lymphomas.
机译:这项研究报告了从7个法国兽医病理实验室收集的608例犬恶性淋巴瘤活检病例的细胞形态学,组织形态学和免疫学特征,以及流行病学和临床数据。它根据更新的基尔分类系统,与世界卫生组织(WHO)分类系统中人类报告的恶性淋巴瘤的形态特征进行了比较。在所描述的肿瘤中,分别有24.5%和75.5%被分类为低度和高度恶性淋巴瘤。出现的临床体征包括全身或局部淋巴结病(82.4%)和结外病(17.6%),涉及皮肤(12.34%)和其他部位(5.26%)。免疫组织化学证实了63.8%的B细胞(CD3–,CD79a +),35.4%的T细胞(CD3 +,CD79a–)和0.8%的无效细胞(CD3–,CD79a–)淋巴瘤。大多数B细胞病例(38.49%)属于高级的中心粒细胞多态性亚型。大多数T细胞病例(8.55%)是高度多形性混合型和大型T细胞淋巴瘤亚型。根据修订的《欧洲淋巴瘤新分类》和WHO犬分类系统以及WHO人类分类系统,一些B细胞肿瘤显示出与滤泡性淋巴瘤和边缘区淋巴瘤一致的形态特征。异常的高级B细胞亚型包括非典型的高级小B细胞淋巴瘤(0.66%),伯基特型B细胞淋巴瘤(1.64%),浆细胞样淋巴瘤(0.99%)和纵隔间变性大B细胞淋巴瘤(0.16%)。罕见的T细胞亚型包括先前未描述的高级犬免疫母细胞T细胞类型(1.15%),罕见的低级原淋巴细胞T细胞淋巴瘤(0.16%)和最近描述的高级犬T细胞实体-侵略性粒细胞大细胞淋巴瘤(0.16%)。边缘区淋巴瘤是常见的(10.86%);滤泡性淋巴瘤很少见(0.49%)。存在犬原发性皮肤恶性淋巴瘤亚型(11.84%)。在犬的年龄和性别方面,B细胞和T细胞恶性淋巴瘤之间无显着差异。发现T细胞淋巴瘤的Boxers明显超标(24.19%)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号